1. Home
  2. LCTX vs DM Comparison

LCTX vs DM Comparison

Compare LCTX & DM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCTX
  • DM
  • Stock Information
  • Founded
  • LCTX 1990
  • DM 2015
  • Country
  • LCTX United States
  • DM United States
  • Employees
  • LCTX N/A
  • DM N/A
  • Industry
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • DM Industrial Machinery/Components
  • Sector
  • LCTX Health Care
  • DM Technology
  • Exchange
  • LCTX Nasdaq
  • DM Nasdaq
  • Market Cap
  • LCTX 166.3M
  • DM 153.0M
  • IPO Year
  • LCTX N/A
  • DM N/A
  • Fundamental
  • Price
  • LCTX $0.60
  • DM $4.41
  • Analyst Decision
  • LCTX Strong Buy
  • DM Hold
  • Analyst Count
  • LCTX 4
  • DM 1
  • Target Price
  • LCTX $4.75
  • DM $5.50
  • AVG Volume (30 Days)
  • LCTX 909.4K
  • DM 290.7K
  • Earning Date
  • LCTX 11-14-2024
  • DM 10-31-2024
  • Dividend Yield
  • LCTX N/A
  • DM N/A
  • EPS Growth
  • LCTX N/A
  • DM N/A
  • EPS
  • LCTX N/A
  • DM N/A
  • Revenue
  • LCTX $8,719,000.00
  • DM $168,283,000.00
  • Revenue This Year
  • LCTX N/A
  • DM $1.01
  • Revenue Next Year
  • LCTX $123.52
  • DM N/A
  • P/E Ratio
  • LCTX N/A
  • DM N/A
  • Revenue Growth
  • LCTX N/A
  • DM N/A
  • 52 Week Low
  • LCTX $0.56
  • DM $3.62
  • 52 Week High
  • LCTX $1.61
  • DM $11.80
  • Technical
  • Relative Strength Index (RSI)
  • LCTX 26.43
  • DM 45.16
  • Support Level
  • LCTX $0.80
  • DM $4.10
  • Resistance Level
  • LCTX $0.97
  • DM $4.60
  • Average True Range (ATR)
  • LCTX 0.07
  • DM 0.23
  • MACD
  • LCTX -0.03
  • DM -0.03
  • Stochastic Oscillator
  • LCTX 9.45
  • DM 53.54

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About DM Desktop Metal Inc.

Desktop Metal Inc manufactures 3D printing to make metal and carbon fiber 3D printing accessible to all engineers, designers, and manufacturers. 3D metal printing helps in the design and development of automotive parts, consumer goods, manufacture of industrial equipment, and design of mechanical systems. The company ships its product to markets in the Americas, Europe Middle East and Africa (EMEA), and Asia Pacific (APAC). It derives maximum revenue from Americas.

Share on Social Networks: